<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7986199" created="29/06/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7986199</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="pyrrolidine_dithiocarbamate" sem="Organic_compound_other">Pyrrolidine dithiocarbamate</term>, a potent inhibitor of <term id="T2" lex="nuclear_factor_kappa_B" sem="Protein_molecule">nuclear factor kappa B</term> (<term id="T3" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term>) activation, prevents apoptosis in human <term id="T4" lex="promyelocytic_leukemia_HL-60_cell" sem="Cell_cultured">promyelocytic leukemia HL-60 cells</term> and <term id="T5" lex="thymocyte" sem="Cell_natural">thymocytes</term>.</sentence>
<event KT="Fact" Manner="High" id="E2">
<type class="Negative_regulation"/>
<theme idref="T3"/>
<cause idref="T1"/>
<clue>Pyrrolidine dithiocarbamate, a <clueManner>potent</clueManner> <clueType>inhibitor</clueType> <linkTheme>of</linkTheme> nuclear factor kappa B (NF-kappa B) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes.</clue>
</event>
<event KT="Other" id="E3">
<type class="Physiological_process"/>
<theme idref="T4"/>
<clue>Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, prevents <clueType>apoptosis</clueType> <linkTheme>in</linkTheme> human promyelocytic leukemia HL-60 cells and thymocytes.</clue>
</event>
<event KT="Other" id="E4">
<type class="Physiological_process"/>
<theme idref="T5"/>
<clue>Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, prevents <clueType>apoptosis</clueType> <linkTheme>in</linkTheme> human promyelocytic leukemia HL-60 cells and thymocytes.</clue>
</event>
<event id="E5">
<type class="Negative_regulation"/>
<theme idref="E2"/>
<cause idref="T1"/>
<clue>Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, <clueType>prevents</clueType> apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes.</clue>
</event>
<event id="E6">
<type class="Negative_regulation"/>
<theme idref="E3"/>
<cause idref="T1"/>
<clue>Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, <clueType>prevents</clueType> apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">We examined the effect of <term id="T6" lex="pyrrolidine_dithiocarbamate" sem="Organic_compound_other">pyrrolidine dithiocarbamate</term> (<term id="T7" lex="PDTC" sem="Organic_compound_other">PDTC</term>), which potently blocks the activation of <term id="T8" lex="nuclear_factor_kappa_B" sem="Protein_molecule">nuclear factor kappa B</term> (<term id="T9" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term>), on the induction of <term id="A2" sem="Other">apoptosis</term> by a variety of <term id="A3" sem="Other">agents</term>.</sentence>
<event KT="Fact" Manner="High" id="E7">
<type class="Negative_regulation"/>
<theme idref="T9"/>
<cause idref="T7"/>
<clue>We examined the effect of pyrrolidine dithiocarbamate (PDTC), which <clueManner>potently</clueManner> <clueType>blocks</clueType> the activation of nuclear factor kappa B (NF-kappa B), on the induction of apoptosis by a variety of agents.</clue>
</event>
<event KT="Other" id="E8">
<type class="Positive_regulation"/>
<theme idref="A2"/>
<cause idref="A3"/>
<clue>We examined the effect of pyrrolidine dithiocarbamate (PDTC), which potently blocks the activation of nuclear factor kappa B (NF-kappa B), on the <clueType>induction</clueType> <linkTheme>of</linkTheme> apoptosis <linkCause>by</linkCause> a variety of agents.</clue>
</event>
<event KT="Investigation" id="E9" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E8"/>
<cause idref="T7"/>
<clue>We <clueKT>examined</clueKT> the <clueType>effect</clueType> <linkCause>of</linkCause> pyrrolidine dithiocarbamate (PDTC), which potently blocks the activation of nuclear factor kappa B (NF-kappa B), <linkTheme>on</linkTheme> the induction of apoptosis by a variety of agents.</clue>
</event>
<sentence id="S3">Treatment of a <term id="T10" lex="human_promyelocytic_leukemia_cell_line" sem="Cell_cultured">human promyelocytic leukemia cell line</term>, <term id="T11" lex="HL-60" sem="Cell_cultured">HL-60</term>, with 10 micrograms/mL <term id="T12" lex="etoposide" sem="Organic_compound_other">etoposide</term> or 2 microM <term id="T13" lex="1-beta-D-arabinofuranosylcytosine" sem="Organic_compound_other">1-beta-D-arabinofuranosylcytosine</term> induced <term id="T14" lex="NF-kappa_B_activation" sem="Other"><term id="T15" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> activation</term> within 1 hr and subsequently caused <term id="A4" sem="Other">apoptosis</term> within 3-4 hr.</sentence>
<event KT="Method" id="E61">
<type class="Artificial_process"/>
<theme idref="T12"/>
<theme idref="T10"/>
<clue><clueType>Treatment</clueType> <linkTheme>of</linkTheme> a human promyelocytic leukemia cell line, HL-60, <linkTheme>with</linkTheme> 10 micrograms/mL etoposide or 2 microM 1-beta-D-arabinofuranosylcytosine induced NF-kappa B activation within 1 hr and subsequently caused apoptosis within 3-4 hr.</clue>
</event>
<event KT="Method" id="E62">
<type class="Artificial_process"/>
<theme idref="T12"/>
<theme idref="T11"/>
<clue><clueType>Treatment</clueType> <linkTheme>of</linkTheme> a human promyelocytic leukemia cell line, HL-60, <linkTheme>with</linkTheme> 10 micrograms/mL etoposide or 2 microM 1-beta-D-arabinofuranosylcytosine induced NF-kappa B activation within 1 hr and subsequently caused apoptosis within 3-4 hr.</clue>
</event>
<event KT="Method" id="E63">
<type class="Artificial_process"/>
<theme idref="T13"/>
<theme idref="T10"/>
<clue><clueType>Treatment</clueType> <linkTheme>of</linkTheme> a human promyelocytic leukemia cell line, HL-60, <linkTheme>with</linkTheme> 10 micrograms/mL etoposide or 2 microM 1-beta-D-arabinofuranosylcytosine induced NF-kappa B activation within 1 hr and subsequently caused apoptosis within 3-4 hr.</clue>
</event>
<event KT="Method" id="E64">
<type class="Artificial_process"/>
<theme idref="T13"/>
<theme idref="T11"/>
<clue><clueType>Treatment</clueType> <linkTheme>of</linkTheme> a human promyelocytic leukemia cell line, HL-60, <linkTheme>with</linkTheme> 10 micrograms/mL etoposide or 2 microM 1-beta-D-arabinofuranosylcytosine induced NF-kappa B activation within 1 hr and subsequently caused apoptosis within 3-4 hr.</clue>
</event>
<event id="E65">
<type class="Positive_regulation"/>
<theme idref="T15"/>
<cause idref="E61"/>
<clue>Treatment of a human promyelocytic leukemia cell line, HL-60, with 10 micrograms/mL etoposide or 2 microM 1-beta-D-arabinofuranosylcytosine induced NF-kappa B <clueType>activation</clueType> <clueTime>within 1 hr</clueTime> and subsequently caused apoptosis within 3-4 hr.</clue>
</event>
<event id="E66">
<type class="Positive_regulation"/>
<theme idref="T15"/>
<cause idref="E62"/>
<clue>Treatment of a human promyelocytic leukemia cell line, HL-60, with 10 micrograms/mL etoposide or 2 microM 1-beta-D-arabinofuranosylcytosine induced NF-kappa B <clueType>activation</clueType> <clueTime>within 1 hr</clueTime> and subsequently caused apoptosis within 3-4 hr.</clue>
</event>
<event id="E67">
<type class="Positive_regulation"/>
<theme idref="T15"/>
<cause idref="E63"/>
<clue>Treatment of a human promyelocytic leukemia cell line, HL-60, with 10 micrograms/mL etoposide or 2 microM 1-beta-D-arabinofuranosylcytosine induced NF-kappa B <clueType>activation</clueType> <clueTime>within 1 hr</clueTime> and subsequently caused apoptosis within 3-4 hr.</clue>
</event>
<event id="E68">
<type class="Positive_regulation"/>
<theme idref="T15"/>
<cause idref="E64"/>
<clue>Treatment of a human promyelocytic leukemia cell line, HL-60, with 10 micrograms/mL etoposide or 2 microM 1-beta-D-arabinofuranosylcytosine induced NF-kappa B <clueType>activation</clueType> <clueTime>within 1 hr</clueTime> and subsequently caused apoptosis within 3-4 hr.</clue>
</event>
<event id="E69">
<type class="Positive_regulation"/>
<theme idref="A4"/>
<cause idref="E65"/>
<clue>Treatment of a human promyelocytic leukemia cell line, HL-60, with 10 micrograms/mL etoposide or 2 microM 1-beta-D-arabinofuranosylcytosine induced NF-kappa B activation within 1 hr and subsequently <clueType>caused</clueType> apoptosis <clueTime>within 3-4 hr</clueTime>.</clue>
</event>
<event id="E70">
<type class="Positive_regulation"/>
<theme idref="A4"/>
<cause idref="E66"/>
<clue>Treatment of a human promyelocytic leukemia cell line, HL-60, with 10 micrograms/mL etoposide or 2 microM 1-beta-D-arabinofuranosylcytosine induced NF-kappa B activation within 1 hr and subsequently <clueType>caused</clueType> apoptosis <clueTime>within 3-4 hr</clueTime>.</clue>
</event>
<event id="E71">
<type class="Positive_regulation"/>
<theme idref="A4"/>
<cause idref="E67"/>
<clue>Treatment of a human promyelocytic leukemia cell line, HL-60, with 10 micrograms/mL etoposide or 2 microM 1-beta-D-arabinofuranosylcytosine induced NF-kappa B activation within 1 hr and subsequently <clueType>caused</clueType> apoptosis <clueTime>within 3-4 hr</clueTime>.</clue>
</event>
<event id="E72">
<type class="Positive_regulation"/>
<theme idref="A4"/>
<cause idref="E68"/>
<clue>Treatment of a human promyelocytic leukemia cell line, HL-60, with 10 micrograms/mL etoposide or 2 microM 1-beta-D-arabinofuranosylcytosine induced NF-kappa B activation within 1 hr and subsequently <clueType>caused</clueType> apoptosis <clueTime>within 3-4 hr</clueTime>.</clue>
</event>
<sentence id="S4">The simultaneous addition of 50-500 microM <term id="T16" lex="PDTC" sem="Organic_compound_other">PDTC</term> with these agents blocked <term id="T17" lex="NF-kappa_B_activation" sem="Other"><term id="T18" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> activation</term> and completely abrogated both <term id="A5" sem="Other">morphologically apoptotic changes</term> and <term id="T19" lex="internucleosomal_DNA_fragmentation" sem="Other">internucleosomal DNA fragmentation</term> for up to 6 hr.</sentence>
<event KT="Other" id="E14">
<type class="Positive_regulation"/>
<theme idref="T18"/>
<clue>The simultaneous addition of 50-500 microM PDTC with these agents blocked NF-kappa B <clueType>activation</clueType> and completely abrogated both morphologically apoptotic changes and internucleosomal DNA fragmentation for up to 6 hr.</clue>
</event>
<event KT="Method" id="E73">
<type class="Artificial_process"/>
<theme idref="T16"/>
<theme idref="T12"/>
<clue>The <clueType>simultaneous addition</clueType> <linkTheme>of</linkTheme> 50-500 microM PDTC <linkTheme>with</linkTheme> <corefTheme idref1="T12">these agents</corefTheme> blocked NF-kappa B activation and completely abrogated both morphologically apoptotic changes and internucleosomal DNA fragmentation for up to 6 hr.</clue>
</event>
<event KT="Method" id="E74">
<type class="Artificial_process"/>
<theme idref="T16"/>
<theme idref="T13"/>
<clue>The <clueType>simultaneous addition</clueType> <linkTheme>of</linkTheme> 50-500 microM PDTC <linkTheme>with</linkTheme> <corefTheme idref1="T13">these agents</corefTheme> blocked NF-kappa B activation and completely abrogated both morphologically apoptotic changes and internucleosomal DNA fragmentation for up to 6 hr.</clue>
</event>
<event id="E15">
<type class="Negative_regulation"/>
<theme idref="E14"/>
<cause idref="E73"/>
<clue>The simultaneous addition of 50-500 microM PDTC with these agents <clueType>blocked</clueType> NF-kappa B activation and completely abrogated both morphologically apoptotic changes and internucleosomal DNA fragmentation for up to 6 hr.</clue>
</event>
<event id="E16">
<type class="Negative_regulation"/>
<theme idref="E14"/>
<cause idref="E74"/>
<clue>The simultaneous addition of 50-500 microM PDTC with these agents <clueType>blocked</clueType> NF-kappa B activation and completely abrogated both morphologically apoptotic changes and internucleosomal DNA fragmentation for up to 6 hr.</clue>
</event>
<event id="E18">
<type class="Negative_regulation"/>
<theme idref="A5"/>
<cause idref="E73"/>
<clue>The simultaneous addition of 50-500 microM PDTC with these agents blocked NF-kappa B activation and completely <clueType>abrogated</clueType> both morphologically apoptotic changes and internucleosomal DNA fragmentation <clueTime>for up to 6 hr</clueTime>.</clue>
</event>
<event id="E19">
<type class="Negative_regulation"/>
<theme idref="A5"/>
<cause idref="E74"/>
<clue>The simultaneous addition of 50-500 microM PDTC with these agents blocked NF-kappa B activation and completely <clueType>abrogated</clueType> both morphologically apoptotic changes and internucleosomal DNA fragmentation <clueTime>for up to 6 hr.</clueTime></clue>
</event>
<event id="E20">
<type class="Negative_regulation"/>
<theme idref="T19"/>
<cause idref="E73"/>
<clue>The simultaneous addition of 50-500 microM PDTC with these agents blocked NF-kappa B activation and completely <clueType>abrogated</clueType> both morphologically apoptotic changes and internucleosomal DNA fragmentation <clueTime>for up to 6 hr</clueTime>.</clue>
</event>
<event id="E21">
<type class="Negative_regulation"/>
<theme idref="T19"/>
<cause idref="E74"/>
<clue>The simultaneous addition of 50-500 microM PDTC with these agents blocked NF-kappa B activation and completely <clueType>abrogated</clueType> both morphologically apoptotic changes and internucleosomal DNA fragmentation <clueTime>for up to 6 hr</clueTime>.</clue>
</event>
<sentence id="S5">However, <term id="T20" lex="PDTC" sem="Organic_compound_other">PDTC</term> failed to inhibit the <term id="T21" lex="endonuclease_activity" sem="Other"><term id="T22" lex="endonuclease" sem="Protein_molecule">endonuclease</term> activity</term> contained in the whole cell lysates.</sentence>
<event Polarity="Negative" assertion="non-exist" id="E22">
<type class="Negative_regulation"/>
<theme idref="T21"/>
<cause idref="T20"/>
<clue>However, PDTC <cluePolarity>failed</cluePolarity> to <clueType>inhibit</clueType> the endonuclease activity contained <clueLoc>in the whole cell lysates.</clueLoc></clue>
</event>
<sentence id="S6">The inhibitory effect of <term id="T23" lex="PDTC" sem="Organic_compound_other">PDTC</term> was also observed in <term id="T24" lex="etoposide" sem="Organic_compound_other">etoposide</term>- and <term id="A8" sem="Organic_compound_other">dexamethasone</term>-induced <term id="A7" sem="Other">apoptosis</term> in <term id="T25" lex="human_thymocyte" sem="Cell_natural">human <term id="T26" lex="thymocyte" sem="Cell_natural">thymocytes</term></term> at a concentration of 1-10 microM.</sentence>
<event id="E23">
<type class="Positive_regulation"/>
<theme idref="A7"/>
<cause idref="T24"/>
<clue>The inhibitory effect of PDTC was also observed in etoposide- and dexamethasone-<clueType>induced</clueType> apoptosis in human thymocytes at a concentration of 1-10 microM.</clue>
</event>
<event id="E24">
<type class="Positive_regulation"/>
<theme idref="A7"/>
<cause idref="A8"/>
<clue>The inhibitory effect of PDTC was also observed in etoposide- and dexamethasone-<clueType>induced</clueType> apoptosis in human thymocytes at a concentration of 1-10 microM.</clue>
</event>
<event id="E25">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="T23"/>
<clue>The <clueType>inhibitory</clueType> effect <linkCause>of</linkCause> PDTC was also <clueKT>observed</clueKT> in etoposide- and dexamethasone-induced apoptosis <clueLoc>in human thymocytes</clueLoc> at a concentration of 1-10 microM.</clue>
</event>
<event id="E26">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="T23"/>
<clue>The <clueType>inhibitory</clueType> effect <linkCause>of</linkCause> PDTC was also <clueKT>observed</clueKT> in etoposide- and dexamethasone-induced apoptosis <clueLoc>in human thymocytes</clueLoc> at a concentration of 1-10 microM.</clue>
</event>
<sentence id="S7">Since <term id="T27" lex="PDTC" sem="Organic_compound_other">PDTC</term> has both <cons id="C1" lex="(AND antioxidant_activity metal-ion chelating_activity)" sem="(AND Other Other)"><frag id="F1">antioxidant</frag> and <frag id="F2">metal-ion chelating</frag> <frag id="F3">activities</frag></cons>, we tested the effects of <term id="T30" lex="N-acetyl-L-cysteine" sem="Amino_acid_monomer">N-acetyl-L-cysteine</term> (<term id="T31" lex="NAC" sem="Amino_acid_monomer">NAC</term>) (<term id="T32" lex="antioxidant" sem="Other">antioxidant</term>) or <term id="T33" lex="o-phenanthroline" sem="Organic_compound_other">o-phenanthroline</term> (<term id="T34" lex="OP" sem="Organic_compound_other">OP</term>) (<term id="T35" lex="metal-ion_chelator" sem="Other">metal-ion chelator</term>) on the induction of <term id="T36" lex="apoptosis" sem="Other">apoptosis</term>.</sentence>
<event KT="Other" id="E27">
<type class="Positive_regulation"/>
<theme idref="T36"/>
<clue>Since PDTC has both antioxidant and metal-ion chelating activities, we tested the effects of N-acetyl-L-cysteine (NAC) (antioxidant) or o-phenanthroline (OP) (metal-ion chelator) on the <clueType>induction</clueType> <linkTheme>of</linkTheme> apoptosis.</clue>
</event>
<event KT="Investigation" id="E28" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E27"/>
<cause idref="T31"/>
<clue>Since PDTC has both antioxidant and metal-ion chelating activities, we <clueKT>tested</clueKT> the <clueType>effects</clueType> <linkCause>of</linkCause> N-acetyl-L-cysteine (NAC) (antioxidant) or o-phenanthroline (OP) (metal-ion chelator) on the induction of apoptosis.</clue>
</event>
<event KT="Investigation" id="E29" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E27"/>
<cause idref="T34"/>
<clue>Since PDTC has both antioxidant and metal-ion chelating activities, we <clueKT>tested</clueKT> the <clueType>effects</clueType> <linkCause>of</linkCause> N-acetyl-L-cysteine (NAC) (antioxidant) or o-phenanthroline (OP) (metal-ion chelator) on the induction of apoptosis.</clue>
</event>
<sentence id="S8">Pretreatment of <term id="A25" sem="Cell_cultured">HL-60 cells</term> or <term id="T37" lex="thymocyte" sem="Cell_natural">thymocytes</term> with 100-500 microM <term id="T38" lex="OP" sem="Organic_compound_other">OP</term> for 2 hr, but not 10-60 mM <term id="T39" lex="NAC" sem="Amino_acid_monomer">NAC</term>, suppressed subsequent occurrence of <term id="T40" lex="apoptosis" sem="Other">apoptosis</term> induced by <term id="T41" lex="etoposide" sem="Organic_compound_other">etoposide</term>.</sentence>
<event KT="Other" id="E30">
<type class="Positive_regulation"/>
<theme idref="T40"/>
<cause idref="T41"/>
<clue>Pretreatment of HL-60 cells or thymocytes with 100-500 microM OP for 2 hr, but not 10-60 mM NAC, suppressed subsequent occurrence of apoptosis <clueType>induced</clueType> <linkCause>by</linkCause> etoposide.</clue>
</event>
<event KT="Method" id="E75">
<type class="Artificial_process"/>
<theme idref="A25"/>
<theme idref="T38"/>
<clue><clueType>Pretreatment</clueType> <linkTheme>of</linkTheme> HL-60 cells or thymocytes <linkTheme>with</linkTheme> 100-500 microM OP for 2 hr, but not 10-60 mM NAC, suppressed subsequent occurrence of apoptosis induced by etoposide.</clue>
</event>
<event KT="Method" id="E76">
<type class="Artificial_process"/>
<theme idref="T37"/>
<theme idref="T38"/>
<clue><clueType>Pretreatment</clueType> <linkTheme>of</linkTheme> HL-60 cells or thymocytes <linkTheme>with</linkTheme> 100-500 microM OP for 2 hr, but not 10-60 mM NAC, suppressed subsequent occurrence of apoptosis induced by etoposide.</clue>
</event>
<event id="E31">
<type class="Negative_regulation"/>
<theme idref="E30"/>
<cause idref="E76"/>
<clue>Pretreatment of HL-60 cells or thymocytes with 100-500 microM OP for 2 hr, but not 10-60 mM NAC, <clueType>suppressed</clueType> subsequent occurrence of apoptosis induced by etoposide.</clue>
</event>
<event id="E32">
<type class="Negative_regulation"/>
<theme idref="E30"/>
<cause idref="E75"/>
<clue>Pretreatment of HL-60 cells or thymocytes with 100-500 microM OP for 2 hr, but not 10-60 mM NAC, <clueType>suppressed</clueType> subsequent occurrence of apoptosis induced by etoposide.</clue>
</event>
<event KT="Method" id="E77">
<type class="Artificial_process"/>
<theme idref="A25"/>
<theme idref="T39"/>
<clue><clueType>Pretreatment</clueType> <linkTheme>of</linkTheme> HL-60 cells or thymocytes <linkTheme>with</linkTheme> 100-500 microM OP for 2 hr, but not 10-60 mM NAC, suppressed subsequent occurrence of apoptosis induced by etoposide.</clue>
</event>
<event KT="Method" id="E78">
<type class="Artificial_process"/>
<theme idref="T37"/>
<theme idref="T39"/>
<clue><clueType>Pretreatment</clueType> <linkTheme>of</linkTheme> HL-60 cells or thymocytes <linkTheme>with</linkTheme> 100-500 microM OP for 2 hr, but not 10-60 mM NAC, suppressed subsequent occurrence of apoptosis induced by etoposide.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E33">
<type class="Negative_regulation"/>
<theme idref="E30"/>
<cause idref="E77"/>
<clue>Pretreatment of HL-60 cells or thymocytes with 100-500 microM OP for 2 hr, but <cluePolarity>not</cluePolarity> 10-60 mM NAC, <clueType>suppressed</clueType> subsequent occurrence of apoptosis induced by etoposide.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E34">
<type class="Negative_regulation"/>
<theme idref="E30"/>
<cause idref="E78"/>
<clue>Pretreatment of HL-60 cells or thymocytes with 100-500 microM OP for 2 hr, but <cluePolarity>not</cluePolarity> 10-60 mM NAC, <clueType>suppressed</clueType> subsequent occurrence of apoptosis induced by etoposide.</clue>
</event>
<sentence id="S9">These results suggest that the activation of <term id="T42" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> plays an important role in the <term id="T43" lex="apoptotic_process" sem="Other">apoptotic process</term> of <term id="T44" lex="human_hematopoietic_cell" sem="Cell_natural">human hematopoietic cells</term>.</sentence>
<event KT="Other" id="E35">
<type class="Positive_regulation"/>
<theme idref="T42"/>
<clue>These results suggest that the <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B plays an important role in the apoptotic process of human hematopoietic cells.</clue>
</event>
<event CL="L2" KT="Analysis" id="E36" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="T43"/>
<cause idref="E35"/>
<clue>These results <clueKT><clueCL>suggest</clueCL></clueKT> that the activation of NF-kappa B <clueType>plays an important role</clueType> <linkTheme>in</linkTheme> the apoptotic process <clueLoc>of human hematopoietic cells</clueLoc>.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
